LNA Santé SA (ENXTPA:LNA) commences share repurchases on January 27, 2022, under the program mandated by the shareholders in the Combined General Meeting held on June 23, 2021. As per the mandate, the company is authorized to repurchase shares up to 970,593 shares, representing 10% of the issued share capital, for a total consideration of not more than € 97.06 million. The shares will be purchased at a price not exceeding €100 per share.

The repurchased shares will be cancelled in part or whole. The purpose of the program is to facilitate the secondary market or to ensure the liquidity of the company's shares, deliver shares on the exercise of rights attached to securities giving access to capital, have shares that can be delivered to its managers and employees as well as to those of companies affiliated with it, under stock option plans or to keep the shares in order to use them in payment or in exchange within the framework of external growth operations. The repurchase program is valid for a period of 18 months, i.e. December 23, 2022.

As of June 23, 2021, the company had 9,705,937 shares issued and 128,191 shares in treasury.